{"id":"NCT00361504","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain","officialTitle":"A One-Year, Randomized, Open-Label, Parallel-Arm, Phase 3 Long-Term Safety Trial, With Controlled Adjustment of Dose, of Multiple Doses of CG5503 PR and Oxycodone CR in Subjects With Chronic Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2008-07","completion":"2008-07","firstPosted":"2006-08-08","resultsPosted":"2009-09-04","lastUpdate":"2014-04-29"},"enrollment":1123,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis, Hip","Osteoarthritis, Knee","Lower Back Pain","Pain"],"interventions":[{"type":"DRUG","name":"Oxycodone CR","otherNames":[]},{"type":"DRUG","name":"Tapentadol (CG5503) ER","otherNames":["CG5503"]}],"arms":[{"label":"Tapentadol (CG5503)","type":"EXPERIMENTAL"},{"label":"Oxycodone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety profile of tapentadol (CG5503) PR at doses of 100 mg - 250 mg administered twice daily over a maximum one year period to patients with at least a 3-month history of low back pain, or pain caused by knee or hip osteoarthritis.","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAE)","timeFrame":"52 weeks","effectByArm":[{"arm":"Tapentadol (CG5503)","deltaMin":766,"sd":2.986},{"arm":"Oxycodone","deltaMin":202,"sd":2.47}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":52,"countries":["United States","Canada"]},"refs":{"pmids":["24985410","23340531","20602712"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":49,"n":894},"commonTop":["Constipation","Nausea","Dizziness","Somnolence","Headache"]}}